Medical Breakthroughs
Leadership
Health Evolution CEO Reading List
Chief executives of providers, payers and life sciences organizations can look to this frequently updated list for articles and resources about health care and leadership.
Read More
Affordability
In a competitive digital health landscape, it’s hard to stand out
With so much activity in the sector, how can innovators distinguish themselves? Among payers and providers, considerations often center on how the solution meets a strategic need, if it can generate ROI, how it differs from others in the marketplace and if it’s easy to integrate.
Read More
Innovations in Care
Clinical research 2.0: An interview with Verily Life Sciences’ Amy Abernethy
Abernethy, the new President of Verily’s Clinical Research Platforms, discusses the need for new clinical trial designs as well as the unbiased data, more sophisticated infrastructure and raw compute power to support them.
Read More
Medical Breakthroughs
Biogen’s Alzheimer’s drug gets FDA approval: 5 things to know
For the first time in nearly 20 years, FDA approved a drug that will treat Alzheimer’s disease. Here are five things for health care CEOs to know about the controversial drug approval.
Read More
Leadership
What to expect at the Health Evolution Summit 2021
The hybrid in-person and virtual Summit 2021 will focus on resetting the agenda with leadership imperatives emerging post-pandemic.
Read More
Medical Breakthroughs
Despite implementation hurdles, precision medicine holds promise in post-COVID era
Coriell Life Sciences CEO Scott Megill recently spoke with Health Evolution about the top-level trends impacting precision medicine, the challenges payers and providers encounter when implementing precision medicine and more.
Read More
COVID
Data Dive: After a year of missed appointments, an increase in diagnoses is coming
Between March and August of last year, utilization of the health care system fell 23 percent, according to a research report. Here’s what that means for an increase in diagnoses across critical diseases.
Read More
COVID
Data dive: What deaths, infections and new vaccines suggest about herd immunity
With death rates and new infections currently on the decline and vaccine doses poised to surge is U.S. herd immunity just weeks away?
Read More
COVID
Pfizer’s COVID-19 vaccine: How will it be distributed and who will receive it first?
Now that its vaccine has demonstrated 90 percent efficacy in Phase 3 clinical trials, Pfizer SVP Peter Honig, MD discusses next steps, timelines for wide availability, and the work still ahead.
Read More
COVID
Four primary care disruptors discuss retail, COVID-19 and more
Health Evolution spoke with leaders at four different disruptor organizations to examine the changing primary care landscape. Use of tech, leveraging community partnerships, and advancing new models of care are a few of the ways these companies are driving growth.
Read MoreCOVID-19 Innovation Guide
The first report in a three-part series on COVID-19 innovation lessons learned by Providence, the pandemic's original ground zero in the U.S. Read the report.
Recent Articles
How health care organizations can work to improve LGBTQ+ care
- Gabriel Perna
Why data needs to drive the transition to value-based care
- Tom Sullivan
